Initial recommendations for performing, benchmarking, and reporting single-cell proteomics experiments
Authors:
Laurent Gatto,
Ruedi Aebersold,
Juergen Cox,
Vadim Demichev,
Jason Derks,
Edward Emmott,
Alexander M. Franks,
Alexander R. Ivanov,
Ryan T. Kelly,
Luke Khoury,
Andrew Leduc,
Michael J. MacCoss,
Peter Nemes,
David H. Perlman,
Aleksandra A. Petelski,
Christopher M. Rose,
Erwin M. Schoof,
Jennifer Van Eyk,
Christophe Vanderaa,
John R. Yates III,
Nikolai Slavov
Abstract:
Analyzing proteins from single cells by tandem mass spectrometry (MS) has become technically feasible. While such analysis has the potential to accurately quantify thousands of proteins across thousands of single cells, the accuracy and reproducibility of the results may be undermined by numerous factors affecting experimental design, sample preparation, data acquisition, and data analysis. Broadl…
▽ More
Analyzing proteins from single cells by tandem mass spectrometry (MS) has become technically feasible. While such analysis has the potential to accurately quantify thousands of proteins across thousands of single cells, the accuracy and reproducibility of the results may be undermined by numerous factors affecting experimental design, sample preparation, data acquisition, and data analysis. Broadly accepted community guidelines and standardized metrics will enhance rigor, data quality, and alignment between laboratories. Here we propose best practices, quality controls, and data reporting recommendations to assist in the broad adoption of reliable quantitative workflows for single-cell proteomics.
△ Less
Submitted 12 September, 2022; v1 submitted 19 July, 2022;
originally announced July 2022.
New views of old proteins: clarifying the enigmatic proteome
Authors:
Participants in a NIH Workshop on Functional,
Integrative Proteomics,
:,
Kristin E. Burnum Johnson,
Thomas P. Conrads,
Richard R. Drake,
Amy E. Herr,
Ravi Iyengar,
Ryan T. Kelly,
Emma Lundberg,
Michael J. MacCoss,
Alexandra Naba,
Garry P. Nolan,
Pavel A. Pevzner,
Karin D. Rodland,
Salvatore Sechi,
Nikolai Slavov,
Jeffrey M. Spraggins,
Jennifer E. Van Eyk,
Marc Vidal,
Christine Vogel,
David R. Walt,
Neil L. Kelleher
Abstract:
All human diseases involve proteins, yet our current tools to characterize and quantify them are limited. To better elucidate proteins across space, time, and molecular composition, we provide provocative projections for technologies to meet the challenges that protein biology presents. With a broad perspective, we discuss grand opportunities to transition the science of proteomics into a more pro…
▽ More
All human diseases involve proteins, yet our current tools to characterize and quantify them are limited. To better elucidate proteins across space, time, and molecular composition, we provide provocative projections for technologies to meet the challenges that protein biology presents. With a broad perspective, we discuss grand opportunities to transition the science of proteomics into a more propulsive enterprise. Extrapolating recent trends, we offer potential futures for a next generation of disruptive approaches to define, quantify and visualize the multiple dimensions of the proteome, thereby transforming our understanding and interactions with human disease in the coming decade.
△ Less
Submitted 17 August, 2021;
originally announced August 2021.
